pilocarpine has been researched along with Glaucoma, Suspect in 86 studies
Pilocarpine: A slowly hydrolyzed muscarinic agonist with no nicotinic effects. Pilocarpine is used as a miotic and in the treatment of glaucoma.
(+)-pilocarpine : The (+)-enantiomer of pilocarpine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of the study was to determine the 24-h effects of pilocarpine 2% ophthalmic solution on intraocular pressure (IOP) and ocular perfusion pressure (OPP) when used in addition to prostaglandin analog (PGA) therapy." | 9.27 | The Diurnal and Nocturnal Effects of Pilocarpine on Intraocular Pressure in Patients Receiving Prostaglandin Analog Monotherapy. ( Kahook, MY; Lynch, AM; Seibold, LK; Wagner, BD, 2018) |
| "This study aimed to compare the safety and effect on intraocular pressure (IOP) of latanoprost given every evening versus pilocarpine/timolol maleate fixed combination (PTFC) given twice daily in patients with primary open-angle glaucoma (POAG) or ocular hypertension (OH)." | 9.13 | Efficacy and safety of latanoprost versus pilocarpine/timolol maleate fixed combination in patients with primary open-angle glaucoma or ocular hypertension. ( Czechowicz-Janicka, K; Kałuzny, BJ; Kałuzny, J; Kecik, D; Sobecki, R; Stewart, JA; Stewart, WC, 2008) |
| "These findings suggest that latanoprost decreases ACD in patients with glaucoma or ocular hypertension after 1 month of treatment." | 9.12 | Short-term effects of latanoprost on anterior chamber depth in patients with glaucoma or ocular hypertension. ( Bolivar, G; Gutiérrez-Ortiz, C; Teus, MA, 2006) |
| "To determine if the intraocular pressure (IOP) effect of pilocarpine at various concentrations is additive to that of bimatoprost and to assess the tolerability of this combination." | 9.11 | Additivity of pilocarpine to bimatoprost in ocular hypertension and early glaucoma. ( Chanis, RA; Fahim, MM; Polikoff, LA; Serle, JB; Sinha, AP; Toor, A, 2005) |
| "To evaluate the efficacy of latanoprost in reducing acute intraocular pressure (IOP) elevation after neodymium:Yag laser iridotomy (LI)." | 9.10 | Use of latanoprost to reduce acute intraocular pressure rise following neodymium: Yag laser iridotomy. ( Cheng, CY; Chiang, SC; Chiu, AW; Chou, JC; Hsu, WM; Liu, CJ; Liu, JH, 2002) |
| "The authors compared the efficacy of apraclonidine 1% versus pilocarpine 4% prophylaxis of post-argon laser trabeculoplasty (ALT) intraocular pressure (IOP) spike." | 9.09 | Efficacy of apraclonidine 1% versus pilocarpine 4% for prophylaxis of intraocular pressure spike after argon laser trabeculoplasty. ( Birt, CM; Chung, HS; Glover, BK; Hughes, BA; Juzych, MS; Kim, C; Ren, J; Shin, DH, 1999) |
| "To compare the effect on intraocular pressure (IOP) of latanoprost monotherapy and timolol-pilocarpine in patients with glaucoma or ocular hypertension with inadequately controlled IOP on topical beta adrenergic antagonists." | 9.09 | Comparison of the intraocular pressure lowering effect of latanoprost and a fixed combination of timolol-pilocarpine eye drops in patients insufficiently controlled with beta adrenergic antagonists. French Latanoprost Study Group, and the Swedish Latanopr ( Malecaze, F; Nordmann, JP; Rouland, JF; Söderström, M, 2000) |
| "To study any interaction between pilocarpine and latanoprost when administered together, and to determine the optimal timing of dosage to maximize reduction of intraocular pressure (IOP)." | 9.09 | Interaction of pilocarpine with latanoprost in patients with glaucoma and ocular hypertension. ( Crosson, CE; Hebert, RL; Kent, AR; Thomas, TJ; Vroman, DT, 1999) |
| "005% administered once daily with that of pilocarpine 2% administered three times daily in patients with primary open-angle glaucoma or ocular hypertension currently on monotherapy with timolol 0." | 9.09 | The additive intraocular pressure-lowering effect of latanoprost 0.005% daily once and pilocarpine 2% t.i.d. in patients with open-angle glaucoma or ocular hypertension. a 6-month, randomized, multicenter study. German Latanoprost Study Group. ( Diestelhorst, M, 2000) |
| "In a randomised prospective controlled study of an exploratory nature, 18 subjects with ocular hypertension had pilocarpine 2% eye drops instilled into a randomly chosen eye three times at 10 min intervals." | 9.09 | The acute effect of pilocarpine on pulsatile ocular blood flow in ocular hypertension. ( Mars, JS; Shaikh, MH, 2001) |
| "Efficacy and safety of ready to use eye drops 2% carteolol-2% pilocarpine combination proved to be comparable to that of eye drops to be reconstituted in the treatment of ocular hypertension poorly controlled by beta-blocker eye drops alone." | 9.08 | [Efficacy and tolerability of 2 presentations of eyedrops combining carteolol 2% and pilocarpine 2% in primary open-angle glaucoma and simple ocular hypertension]. ( Charlin, JF; Cohn, H; Dascotte, JC; George, JL; Lesure, P; Massin, G; Massin, M; Maurin, JF; Renard, JP; Sirbat, D, 1995) |
| "To report the results of two studies on the use of dorzolamide as adjunctive therapy to timolol in patients with elevated intraocular pressure (IOP)." | 9.08 | The use of dorzolamide and pilocarpine as adjunctive therapy to timolol in patients with elevated intraocular pressure. The Dorzolamide Additivity Study Group. ( Clineschmidt, CM; Strahlman, ER; Tipping, R; Vogel, R, 1996) |
| "To evaluate the effects of PhXA41, a new prostaglandin analogue, on the intraocular pressure (IOP) in patients receiving pilocarpine treatment and the effects of pilocarpine in patients receiving PhXA41 treatment." | 9.07 | Interaction of PhXA41, a new prostaglandin analogue, with pilocarpine. A study on patients with elevated intraocular pressure. ( Friström, B; Nilsson, SE, 1993) |
| "5% timolol and 2% pilocarpine (Fotil, Leiras, Finland, and Timpilo, MSD, USA) in patients with glaucoma or ocular hypertension." | 9.07 | Efficacy and safety of timolol/pilocarpine combination drops in glaucoma patients. ( Palkama, A; Uusitalo, RJ, 1994) |
| "To assess the effects of pilocarpine (PC) incorporated into an in situ gelling vehicle, submicron emulsion vehicle, polyvinyl alcohol vehicle and PC solution on intraocular pressure (IOP) in rabbits with carbomer-induced elevation of IOP." | 7.71 | [Effects of pilocarpine in new ophthalmic formulations on intraocular pressure in rabbits with ocular hypertension]. ( Chen, Z; Song, J; Xu, Y, 2002) |
| "To determine the incidence of intraocular pressure (IOP) rise of varying degrees after laser peripheral iridotomy (LPI) in patients with and without glaucoma treated perioperatively with pilocarpine and apraclonidine." | 7.70 | The rarity of clinically significant rise in intraocular pressure after laser peripheral iridotomy with apraclonidine. ( Gangnon, R; Heatley, GA; Kaufman, PL; Lewis, R; Perkins, TW, 1998) |
| "Thirty patients with ocular hypertension or open-angle glaucoma were tested to see if, and to what extent, guanethidine/dipivefrin and pilocarpine produced a supplementary reduction in intraocular pressure." | 7.67 | [Guanethidine/dipivefrin and pilocarpine in the treatment of increased intraocular pressure]. ( Dausch, D; Ober, M; Scharrer, A, 1987) |
| "Many patients with glaucoma or ocular hypertension initially receive beta-blocker monotherapy to control intraocular pressure (IOP), but some of these patients will require an additional IOP-lowering agent within 1 year." | 6.69 | Comparison of dorzolamide and pilocarpine as adjunctive therapy in patients with open-angle glaucoma and ocular hypertension. ( Gormley, GJ; Hartenbaum, D; Liss, C; Maloney, S; Vaccarelli, L; Wilson, H, 1999) |
| "4% pilocarpine was compared with that of timolol 0." | 6.66 | Timolol/pilocarpine combination eye drops in open angle glaucoma and in ocular hypertension. A controlled randomized study. ( Aasved, H; Høvding, G, 1987) |
| "Intraocular pressure was controlled by intracameral cannulation of mouse eyes while imaging using spectral-domain optical coherence tomography (SD-OCT)." | 5.40 | Pilocarpine-induced dilation of Schlemm's canal and prevention of lumen collapse at elevated intraocular pressures in living mice visualized by OCT. ( Chiu, SJ; Farsiu, S; Gonzalez, P; Li, G; Lütjen-Drecoll, E; Overby, DR; Stamer, WD, 2014) |
| "The purpose of the study was to determine the 24-h effects of pilocarpine 2% ophthalmic solution on intraocular pressure (IOP) and ocular perfusion pressure (OPP) when used in addition to prostaglandin analog (PGA) therapy." | 5.27 | The Diurnal and Nocturnal Effects of Pilocarpine on Intraocular Pressure in Patients Receiving Prostaglandin Analog Monotherapy. ( Kahook, MY; Lynch, AM; Seibold, LK; Wagner, BD, 2018) |
| "This study aimed to compare the safety and effect on intraocular pressure (IOP) of latanoprost given every evening versus pilocarpine/timolol maleate fixed combination (PTFC) given twice daily in patients with primary open-angle glaucoma (POAG) or ocular hypertension (OH)." | 5.13 | Efficacy and safety of latanoprost versus pilocarpine/timolol maleate fixed combination in patients with primary open-angle glaucoma or ocular hypertension. ( Czechowicz-Janicka, K; Kałuzny, BJ; Kałuzny, J; Kecik, D; Sobecki, R; Stewart, JA; Stewart, WC, 2008) |
| "Three hundred forty consecutive patients with a new diagnosis of POAG or OH, or previously treated only with a beta-blocker and after an appropriate washout period, were treated with latanoprost for 1 month and then divided into three groups on the basis of the reduction in intraocular pressure (IOP): nonresponders (<15%), responders (> or =15% but <30%), and high-responders (> or =30%)." | 5.12 | An evaluation of the rate of nonresponders to latanoprost therapy. ( Carassa, R; Gandolfi, S; Manni, G; Marchini, G; Mastropasqua, L; Montanari, P; Orzalesi, N; Quaranta, L; Ratiglia, R; Rossetti, L; Traverso, C; Uva, M, 2006) |
| "These findings suggest that latanoprost decreases ACD in patients with glaucoma or ocular hypertension after 1 month of treatment." | 5.12 | Short-term effects of latanoprost on anterior chamber depth in patients with glaucoma or ocular hypertension. ( Bolivar, G; Gutiérrez-Ortiz, C; Teus, MA, 2006) |
| "To determine if the intraocular pressure (IOP) effect of pilocarpine at various concentrations is additive to that of bimatoprost and to assess the tolerability of this combination." | 5.11 | Additivity of pilocarpine to bimatoprost in ocular hypertension and early glaucoma. ( Chanis, RA; Fahim, MM; Polikoff, LA; Serle, JB; Sinha, AP; Toor, A, 2005) |
| "To evaluate the efficacy of latanoprost in reducing acute intraocular pressure (IOP) elevation after neodymium:Yag laser iridotomy (LI)." | 5.10 | Use of latanoprost to reduce acute intraocular pressure rise following neodymium: Yag laser iridotomy. ( Cheng, CY; Chiang, SC; Chiu, AW; Chou, JC; Hsu, WM; Liu, CJ; Liu, JH, 2002) |
| "To compare the effect on intraocular pressure (IOP) of latanoprost monotherapy and timolol-pilocarpine in patients with glaucoma or ocular hypertension with inadequately controlled IOP on topical beta adrenergic antagonists." | 5.09 | Comparison of the intraocular pressure lowering effect of latanoprost and a fixed combination of timolol-pilocarpine eye drops in patients insufficiently controlled with beta adrenergic antagonists. French Latanoprost Study Group, and the Swedish Latanopr ( Malecaze, F; Nordmann, JP; Rouland, JF; Söderström, M, 2000) |
| "0% pilocarpine given concomitantly, and to determine patient preference, tolerability, and impact on daily life in patients with elevated intraocular pressure (IOP)." | 5.09 | The dorzolamide/timolol combination versus timolol plus pilocarpine: patient preference and impact on daily life. United States Patient Preference Study Group. International Patient Preference Study Group. ( Adamsons, I; Gross, R; Pearson, J; Rusk, C; Sverrisson, T, 1999) |
| "In a randomised prospective controlled study of an exploratory nature, 18 subjects with ocular hypertension had pilocarpine 2% eye drops instilled into a randomly chosen eye three times at 10 min intervals." | 5.09 | The acute effect of pilocarpine on pulsatile ocular blood flow in ocular hypertension. ( Mars, JS; Shaikh, MH, 2001) |
| "The authors compared the efficacy of apraclonidine 1% versus pilocarpine 4% prophylaxis of post-argon laser trabeculoplasty (ALT) intraocular pressure (IOP) spike." | 5.09 | Efficacy of apraclonidine 1% versus pilocarpine 4% for prophylaxis of intraocular pressure spike after argon laser trabeculoplasty. ( Birt, CM; Chung, HS; Glover, BK; Hughes, BA; Juzych, MS; Kim, C; Ren, J; Shin, DH, 1999) |
| "Compared with baseline, pilocarpine reduced intraocular pressure from 18." | 5.09 | Potential mechanism for the additivity of pilocarpine and latanoprost. ( Camras, CB; Toris, CB; Yablonski, ME; Zhan, GL; Zhao, J, 2001) |
| "To study any interaction between pilocarpine and latanoprost when administered together, and to determine the optimal timing of dosage to maximize reduction of intraocular pressure (IOP)." | 5.09 | Interaction of pilocarpine with latanoprost in patients with glaucoma and ocular hypertension. ( Crosson, CE; Hebert, RL; Kent, AR; Thomas, TJ; Vroman, DT, 1999) |
| "005% administered once daily with that of pilocarpine 2% administered three times daily in patients with primary open-angle glaucoma or ocular hypertension currently on monotherapy with timolol 0." | 5.09 | The additive intraocular pressure-lowering effect of latanoprost 0.005% daily once and pilocarpine 2% t.i.d. in patients with open-angle glaucoma or ocular hypertension. a 6-month, randomized, multicenter study. German Latanoprost Study Group. ( Diestelhorst, M, 2000) |
| "This study compared brimonidine with latanoprost as adjunctive therapy for the treatment of open-angle glaucoma and ocular hypertension." | 5.09 | Comparison of brimonidine with latanoprost in the adjunctive treatment of glaucoma. ALPHAGAN/XALATAN Study Group. ( Samuelson, TW; Simmons, ST, 2000) |
| "5% timolol twice daily, was conducted on 81 patients with elevated intraocular pressure (IOP)." | 5.08 | A multicenter study comparing dorzolamide and pilocarpine as adjunctive therapy to timolol: patient preference and impact on daily life. ( Adamsons, I; Snyder, E; Strohmaier, K, 1998) |
| "The safety of dorzolamide was evaluated in patients with open-angle glaucoma or ocular hypertension over a 2-year period." | 5.08 | Two-year safety study of dorzolamide as monotherapy and with timolol and pilocarpine. Dorzolamide Safety Study Group. ( Adamsons, IA; Boyle, JE; Ostrov, CS; Polis, A, 1998) |
| "Efficacy and safety of ready to use eye drops 2% carteolol-2% pilocarpine combination proved to be comparable to that of eye drops to be reconstituted in the treatment of ocular hypertension poorly controlled by beta-blocker eye drops alone." | 5.08 | [Efficacy and tolerability of 2 presentations of eyedrops combining carteolol 2% and pilocarpine 2% in primary open-angle glaucoma and simple ocular hypertension]. ( Charlin, JF; Cohn, H; Dascotte, JC; George, JL; Lesure, P; Massin, G; Massin, M; Maurin, JF; Renard, JP; Sirbat, D, 1995) |
| "To report the results of two studies on the use of dorzolamide as adjunctive therapy to timolol in patients with elevated intraocular pressure (IOP)." | 5.08 | The use of dorzolamide and pilocarpine as adjunctive therapy to timolol in patients with elevated intraocular pressure. The Dorzolamide Additivity Study Group. ( Clineschmidt, CM; Strahlman, ER; Tipping, R; Vogel, R, 1996) |
| " In studies 1 and 2, there was a mean reduction in intraocular pressure from a betaxolol baseline of approximately 3 to 4 mmHg." | 5.08 | Ocular hypotensive efficacy and safety of a combined formulation of betaxolol and pilocarpine. ( Robin, AL, 1996) |
| "To evaluate the effects of PhXA41, a new prostaglandin analogue, on the intraocular pressure (IOP) in patients receiving pilocarpine treatment and the effects of pilocarpine in patients receiving PhXA41 treatment." | 5.07 | Interaction of PhXA41, a new prostaglandin analogue, with pilocarpine. A study on patients with elevated intraocular pressure. ( Friström, B; Nilsson, SE, 1993) |
| "5% timolol and 2% pilocarpine (Fotil, Leiras, Finland, and Timpilo, MSD, USA) in patients with glaucoma or ocular hypertension." | 5.07 | Efficacy and safety of timolol/pilocarpine combination drops in glaucoma patients. ( Palkama, A; Uusitalo, RJ, 1994) |
| "Between July 1983 and January 1986, 54 patients with open-angle glaucoma or ocular hypertension were treated for 3 months with 2% pilocarpine hydrochloride (given four times daily) and one of two beta-adrenoceptor blocking drugs, levobunolol hydrochloride (0." | 5.06 | Treatment of elevated intraocular pressure with concurrent levobunolol and pilocarpine. ( Batoosingh, AL; David, R; Elman, J; Masi, R; Novack, GD; Ober, M; Sears, ML, 1987) |
| "A clinical comparison of an emulsion containing a new pilocarpine polymer (Polym) compound to that of a traditional pilocarpine salt solution (Plc) on the intraocular pressure (IOP) has been performed in 40 open-angle patients treated with the long acting pilocarpine-complex for 120 days." | 5.05 | [Effect on pressure after instillation of a drop of depot-pilocarpine. Clinical results of its medium-term action]. ( Andermann, C; Arne, JL; Bec, P; Mialhe, D; Vende, D, 1983) |
| "Latanoprost, a prodrug of a prostaglandin F(2alpha) analog, is a potent ocular hypotensive agent, reducing intraocular pressure (IOP) primarily by increasing aqueous humor drainage through the uveoscleral outflow pathway." | 4.81 | Latanoprost and cholinergic agonists in combination. ( Alm, A; Camras, CB; Toris, CB, 2002) |
| "To assess the effects of pilocarpine (PC) incorporated into an in situ gelling vehicle, submicron emulsion vehicle, polyvinyl alcohol vehicle and PC solution on intraocular pressure (IOP) in rabbits with carbomer-induced elevation of IOP." | 3.71 | [Effects of pilocarpine in new ophthalmic formulations on intraocular pressure in rabbits with ocular hypertension]. ( Chen, Z; Song, J; Xu, Y, 2002) |
| "To determine the incidence of intraocular pressure (IOP) rise of varying degrees after laser peripheral iridotomy (LPI) in patients with and without glaucoma treated perioperatively with pilocarpine and apraclonidine." | 3.70 | The rarity of clinically significant rise in intraocular pressure after laser peripheral iridotomy with apraclonidine. ( Gangnon, R; Heatley, GA; Kaufman, PL; Lewis, R; Perkins, TW, 1998) |
| " While topical timolol lowered intraocular pressure and aqueous humor inflow in ocular hypertensive rabbits, pilocarpine did not produce any significant effect." | 3.70 | Aqueous humor dynamics in alpha-chymotrypsin-induced ocular hypertensive rabbits. ( Melena, J; Puras, G; Santafé, J; Segarra-Doménech, J, 1999) |
| " Ocular hypertension in the rabbit was induced by alpha-chymotrypsin or by water loading." | 3.70 | Pharmacological profile of a new topical pilocarpine formulation. ( Bucolo, C; Mangiafico, P, 1999) |
| " Ocular hypertension in the rabbit was induced by alpha-chymotrypsin or by water loading." | 3.70 | Pharmacological evaluation of a new timolol/pilocarpine formulation. ( Bucolo, C; Mangiafico, S; Spadaro, A, 1998) |
| "Thirty patients with ocular hypertension or open-angle glaucoma were tested to see if, and to what extent, guanethidine/dipivefrin and pilocarpine produced a supplementary reduction in intraocular pressure." | 3.67 | [Guanethidine/dipivefrin and pilocarpine in the treatment of increased intraocular pressure]. ( Dausch, D; Ober, M; Scharrer, A, 1987) |
| "A comparative study comprising 30 patients with glaucoma and 11 ocular hypertensives showed that pilocarpine 2%-4% and metoprolol 3% lowered the intraocular pressure to the same extent over a 4-week period." | 3.66 | Metoprolol eyedrops 3%, a short-term comparison with pilocarpine and a five-month follow-up study. (Multicenter). ( Ahrendt, N; Buhl, H; Byrn, E; Nielsen, PG, 1982) |
| "Many patients with glaucoma or ocular hypertension initially receive beta-blocker monotherapy to control intraocular pressure (IOP), but some of these patients will require an additional IOP-lowering agent within 1 year." | 2.69 | Comparison of dorzolamide and pilocarpine as adjunctive therapy in patients with open-angle glaucoma and ocular hypertension. ( Gormley, GJ; Hartenbaum, D; Liss, C; Maloney, S; Vaccarelli, L; Wilson, H, 1999) |
| "Intraocular pressure was consistently lower with the combination treatment than with timolol or pilocarpine alone." | 2.67 | Combined timolol and pilocarpine vs pilocarpine alone and timolol alone in the treatment of glaucoma. ( Geyer, O; Krakowski, D; Lazar, M; Nemet, P; Zadok, D; Zadok, J, 1994) |
| "4% pilocarpine was compared with that obtained by 1 dose of timolol 0." | 2.67 | Twelve-hour IOP control obtained by a single dose of timolol/pilocarpine combination eye drops. ( Aasved, H; Bergaust, B; Bulie, T; Høvding, G; Løfors, KT; Viksmoen, L, 1990) |
| "Intraocular pressure was measured by applanation tonometry at 0, 30, 60, 120, and 240 minutes." | 2.66 | The consensual ophthalmotonic reaction. ( Gibbens, MV, 1988) |
| "One half of 20 patients (40 eyes) with ocular hypertension and occludable angles, some with peripheral anterior synechiae, were randomly assigned for treatment by Nd:YAG laser iridotomy." | 2.66 | Role of Nd:YAG peripheral iridectomy in the management of ocular hypertension with a narrow angle. ( Hitchings, RA; Pooinasawmy, D; Romano, JH, 1988) |
| "4% pilocarpine was compared with that of timolol 0." | 2.66 | Timolol/pilocarpine combination eye drops in open angle glaucoma and in ocular hypertension. A controlled randomized study. ( Aasved, H; Høvding, G, 1987) |
| "with pilocarpine 2." | 2.65 | One-month crossover trial comparing the intraocular pressure control of 3.4% Piloplex twice daily with 2.0% pilocarpine four times daily. ( Duzman, E; Quinn, CA; Warman, A; Warman, R, 1982) |
| "Steroid-induced ocular hypertension (SIOH) is associated with topical and systemic use of steroids." | 1.42 | Anterior and posterior segment changes in rat eyes with chronic steroid administration and their responsiveness to antiglaucoma drugs. ( Agarwal, P; Agarwal, R; Ismail, NM; Kannan Kutty, M; Kapitonova, MY; Razali, N; Salmah Bakar, N; Smirnov, A, 2015) |
| "Intraocular pressure was controlled by intracameral cannulation of mouse eyes while imaging using spectral-domain optical coherence tomography (SD-OCT)." | 1.40 | Pilocarpine-induced dilation of Schlemm's canal and prevention of lumen collapse at elevated intraocular pressures in living mice visualized by OCT. ( Chiu, SJ; Farsiu, S; Gonzalez, P; Li, G; Lütjen-Drecoll, E; Overby, DR; Stamer, WD, 2014) |
| "To characterize the microbead-induced ocular hypertension (OHT) mouse model and investigate its potential use for preclinical screening and evaluation of ocular hypotensive agents, we tested the model's responses to major antiglaucoma drugs." | 1.38 | Microbead-induced ocular hypertensive mouse model for screening and testing of aqueous production suppressants for glaucoma. ( Chen, DF; Chen, H; Cho, KS; Guo, W; Luo, G; Pang, IH; Wang, WH; Yang, Q; Yu, D, 2012) |
| "To examine the relationship of ocular hypertension (O." | 1.33 | [Ocular hypertension and glaucoma]. ( Radian, AB, 2005) |
| "Twenty cases(40 eyes) with ocular hypertension or primary open angle glaucoma(POAG) in early stage were treated by 4% PG(once per night) and PS(4 times per day)." | 1.31 | [Clinical observation on the effect of 4% pilocarpine gel used one dose per day in the treatment of glaucoma]. ( Chen, X; Liang, L; Yie, T, 2000) |
| "Postoperative ocular hypertension is not related to ultrasonic duration." | 1.31 | [Factors influencing early post surgical ocular hypertension after phacoemulsification]. ( Fajnkuchen, F; Feys, J; Salvanet-Bouccara, A, 2000) |
| "20 patients with open angle glaucoma or ocular hypertension and an elevated intraocular pressure (IOP) over 21 mmHg and without prior oral CAI-treatment were included in this study." | 1.30 | Influence of dorzolamide on corneal thickness, endothelial cell count and corneal sensibility. ( Barisani, T; Baumgartner, I; Biowski, R; Hommer, A; Kaminski, S; Koyuncu, D, 1998) |
| "Twenty-nine of these were treated for glaucoma and eight followed for ocular hypertension without treatment." | 1.30 | Five-year follow-up of treated patients with glaucoma using resolution perimetry. ( Martin, L; Wanger, P, 1998) |
| "Fifty-four eyes of 45 patients with ocular hypertension developed early glaucomatous optic disc or visual field changes after a mean follow-up of 5." | 1.29 | Visual field prognosis in early glaucoma. A long-term clinical follow-up. ( Odberg, T, 1993) |
| "In 35 of the 56 treated glaucoma patients the thresholds improved more than 0." | 1.29 | The effect of treatment on the results of high-pass resolution perimetry in glaucoma. ( Martin-Boglind, L; Wanger, P, 1994) |
| "Pilocarpine was used to treat persistent epithelial defects or raised intraocular pressure." | 1.29 | Pilocarpine-associated allograft rejection in postkeratoplasty patients. ( Assil, KK; Massry, GG, 1995) |
| "In the 42 patients with glaucoma or ocular hypertension the mean intraocular pressure (IOP) was unchanged following iridectomy; 45% of eyes which showed glaucomatous optic disc damage at presentation and 25." | 1.28 | Can the pilocarpine phenylephrine provocative test be used to detect covert angle closure? ( Wishart, PK, 1991) |
| "Pretreatment with indomethacin or pilocarpine specifically attenuated the ability of MK-422 to lower IOP suggesting that biosynthesis of prostaglandins and uveoscleral outflow pathways are important in mediating the ocular hypotension." | 1.28 | Prostaglandins mediate the ocular hypotensive action of the angiotensin converting enzyme inhibitor MK-422 (enalaprilat) in African green monkeys. ( Lotti, VJ; Pawlowski, N, 1990) |
| " Short- or long-term use of timolol neither caused, increased nor decreased leak of the dye from the iris vessels, either at the pupillary border, or in other areas of the iris." | 1.27 | Vascular effects of timolol and pilocarpine in the iris. A simultaneous bilateral fluorescein angiographic study. ( Airaksinen, PJ; Alanko, HI, 1983) |
| "An initial response of ocular hypertension followed by hypotension was observed in all of the animals tested." | 1.27 | Laser-induced glaucoma in rabbits. ( Gherezghiher, T; Koss, MC; March, WF; Nordquist, RE, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 21 (24.42) | 18.7374 |
| 1990's | 36 (41.86) | 18.2507 |
| 2000's | 22 (25.58) | 29.6817 |
| 2010's | 7 (8.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Robciuc, A | 1 |
| Witos, J | 1 |
| Ruokonen, SK | 1 |
| Rantamäki, AH | 1 |
| Pisella, PJ | 1 |
| Wiedmer, SK | 1 |
| Holopainen, JM | 1 |
| Seibold, LK | 1 |
| Wagner, BD | 1 |
| Lynch, AM | 1 |
| Kahook, MY | 1 |
| Gharbiya, M | 1 |
| Colica, C | 1 |
| Campagna, O | 1 |
| De Vico, U | 1 |
| Cruciani, F | 1 |
| Li, G | 1 |
| Farsiu, S | 1 |
| Chiu, SJ | 1 |
| Gonzalez, P | 1 |
| Lütjen-Drecoll, E | 2 |
| Overby, DR | 1 |
| Stamer, WD | 1 |
| Razali, N | 1 |
| Agarwal, R | 1 |
| Agarwal, P | 1 |
| Kapitonova, MY | 1 |
| Kannan Kutty, M | 1 |
| Smirnov, A | 1 |
| Salmah Bakar, N | 1 |
| Ismail, NM | 1 |
| Zhang, L | 1 |
| Weizer, JS | 1 |
| Musch, DC | 1 |
| Kałuzny, J | 2 |
| Sobecki, R | 1 |
| Czechowicz-Janicka, K | 2 |
| Kecik, D | 1 |
| Kałuzny, BJ | 1 |
| Stewart, JA | 2 |
| Stewart, WC | 2 |
| Baba, T | 1 |
| Hirooka, K | 1 |
| Takagishi, M | 1 |
| Sato, S | 1 |
| Shiraga, F | 1 |
| Yang, Q | 1 |
| Cho, KS | 1 |
| Chen, H | 1 |
| Yu, D | 1 |
| Wang, WH | 1 |
| Luo, G | 1 |
| Pang, IH | 1 |
| Guo, W | 1 |
| Chen, DF | 1 |
| Toris, CB | 3 |
| Alm, A | 1 |
| Camras, CB | 2 |
| Diestelhorst, M | 2 |
| Nordmann, JP | 2 |
| Yie, T | 1 |
| Liang, L | 1 |
| Chen, X | 1 |
| Xu, Y | 1 |
| Chen, Z | 1 |
| Song, J | 1 |
| Kałuzny, JJ | 1 |
| Szaflik, J | 1 |
| Orzalkiewicz, A | 1 |
| Zaleska, A | 1 |
| Krajewska, M | 1 |
| Leech, JN | 1 |
| YANKELEVICH, IJ | 1 |
| Doyle, A | 1 |
| O'Connor, M | 1 |
| Călugăru, M | 1 |
| Călugăru, D | 1 |
| Toor, A | 1 |
| Chanis, RA | 1 |
| Polikoff, LA | 1 |
| Fahim, MM | 1 |
| Sinha, AP | 1 |
| Serle, JB | 1 |
| Radian, AB | 1 |
| Rossetti, L | 1 |
| Gandolfi, S | 1 |
| Traverso, C | 1 |
| Montanari, P | 1 |
| Uva, M | 1 |
| Manni, G | 1 |
| Carassa, R | 1 |
| Mastropasqua, L | 1 |
| Quaranta, L | 1 |
| Marchini, G | 1 |
| Ratiglia, R | 1 |
| Orzalesi, N | 1 |
| Novak-Laus, K | 1 |
| Masnec-Paskvalin, S | 1 |
| Korsić, J | 1 |
| Iveković, R | 1 |
| Zorić-Geber, M | 1 |
| Mandić, Z | 1 |
| Gutiérrez-Ortiz, C | 1 |
| Teus, MA | 1 |
| Bolivar, G | 1 |
| Andermann, C | 1 |
| Mialhe, D | 1 |
| Arne, JL | 1 |
| Vende, D | 1 |
| Bec, P | 1 |
| Ofner, S | 1 |
| Samples, JR | 1 |
| van Buskirk, EM | 1 |
| Duzman, E | 1 |
| Quinn, CA | 1 |
| Warman, A | 1 |
| Warman, R | 1 |
| Airaksinen, PJ | 1 |
| Alanko, HI | 1 |
| Nielsen, PG | 1 |
| Ahrendt, N | 1 |
| Buhl, H | 1 |
| Byrn, E | 1 |
| Massry, GG | 1 |
| Assil, KK | 1 |
| Martin-Boglind, L | 1 |
| Wanger, P | 2 |
| Uusitalo, RJ | 1 |
| Palkama, A | 1 |
| Naveh, N | 1 |
| Muchtar, S | 1 |
| Benita, S | 1 |
| John, M | 1 |
| Souchek, J | 1 |
| Noblitt, RL | 1 |
| Boleyn, KL | 1 |
| Davis, LC | 1 |
| Sharir, M | 1 |
| Zimmerman, TJ | 2 |
| del Negro, RG | 1 |
| Ball, SF | 1 |
| Kooner, KS | 1 |
| Odberg, T | 1 |
| Zadok, D | 1 |
| Geyer, O | 1 |
| Zadok, J | 1 |
| Lazar, M | 1 |
| Krakowski, D | 1 |
| Nemet, P | 1 |
| Friström, B | 1 |
| Nilsson, SE | 1 |
| Sirbat, D | 1 |
| Charlin, JF | 1 |
| Cohn, H | 1 |
| Dascotte, JC | 1 |
| George, JL | 1 |
| Lesure, P | 1 |
| Massin, M | 1 |
| Massin, G | 1 |
| Maurin, JF | 1 |
| Renard, JP | 1 |
| Strahlman, ER | 2 |
| Vogel, R | 1 |
| Tipping, R | 1 |
| Clineschmidt, CM | 1 |
| Robin, AL | 1 |
| Barber, BL | 1 |
| Laibovitz, R | 1 |
| Guess, HA | 1 |
| Reines, SA | 1 |
| Kondo, T | 1 |
| Miyazawa, D | 1 |
| Unigame, K | 1 |
| Kurimoto, Y | 1 |
| Martin, L | 1 |
| Bucolo, C | 2 |
| Spadaro, A | 1 |
| Mangiafico, S | 1 |
| Kaminski, S | 1 |
| Hommer, A | 1 |
| Koyuncu, D | 1 |
| Biowski, R | 1 |
| Barisani, T | 1 |
| Baumgartner, I | 1 |
| Taverniti, L | 1 |
| Voccia, L | 1 |
| Amoroso, L | 1 |
| De Stefano, C | 1 |
| Virno, M | 1 |
| Strohmaier, K | 1 |
| Snyder, E | 1 |
| Adamsons, I | 2 |
| Lewis, R | 1 |
| Perkins, TW | 1 |
| Gangnon, R | 1 |
| Kaufman, PL | 1 |
| Heatley, GA | 1 |
| Adamsons, IA | 1 |
| Polis, A | 1 |
| Ostrov, CS | 1 |
| Boyle, JE | 1 |
| Kalmann, R | 1 |
| Mourits, MP | 1 |
| Melena, J | 1 |
| Santafé, J | 1 |
| Segarra-Doménech, J | 1 |
| Puras, G | 1 |
| Ren, J | 1 |
| Shin, DH | 1 |
| Chung, HS | 1 |
| Birt, CM | 1 |
| Glover, BK | 1 |
| Juzych, MS | 1 |
| Hughes, BA | 1 |
| Kim, C | 1 |
| Kent, AR | 1 |
| Vroman, DT | 1 |
| Thomas, TJ | 1 |
| Hebert, RL | 1 |
| Crosson, CE | 1 |
| Hartenbaum, D | 1 |
| Maloney, S | 1 |
| Vaccarelli, L | 1 |
| Liss, C | 1 |
| Wilson, H | 1 |
| Gormley, GJ | 1 |
| Sverrisson, T | 1 |
| Gross, R | 1 |
| Pearson, J | 1 |
| Rusk, C | 1 |
| Mangiafico, P | 1 |
| Söderström, M | 1 |
| Rouland, JF | 1 |
| Malecaze, F | 1 |
| Simmons, ST | 1 |
| Samuelson, TW | 1 |
| Feys, J | 1 |
| Fajnkuchen, F | 1 |
| Salvanet-Bouccara, A | 1 |
| Shaikh, MH | 1 |
| Mars, JS | 1 |
| Gottanka, J | 1 |
| Johnson, DH | 1 |
| Martus, P | 1 |
| Zhan, GL | 1 |
| Zhao, J | 1 |
| Yablonski, ME | 1 |
| Liu, CJ | 1 |
| Cheng, CY | 1 |
| Chiang, SC | 1 |
| Chiu, AW | 1 |
| Chou, JC | 1 |
| Hsu, WM | 1 |
| Liu, JH | 1 |
| Maas, S | 2 |
| Ros, FE | 2 |
| De Heer, LJ | 2 |
| De Keizer, RJ | 2 |
| Chang, JS | 1 |
| Lee, DA | 1 |
| Petursson, G | 1 |
| Spaeth, G | 1 |
| Hoskins, HD | 1 |
| Mills, R | 1 |
| Brown, R | 1 |
| Kass, M | 1 |
| Lue, J | 1 |
| Wishart, PK | 1 |
| Lotti, VJ | 1 |
| Pawlowski, N | 1 |
| Pfeiffer, N | 1 |
| Grehn, F | 1 |
| Hennekes, R | 1 |
| Garus, H | 1 |
| Løfors, KT | 1 |
| Høvding, G | 2 |
| Viksmoen, L | 1 |
| Aasved, H | 2 |
| Bergaust, B | 1 |
| Bulie, T | 1 |
| Crick, RP | 1 |
| Newson, RB | 1 |
| Shipley, MJ | 1 |
| Blackmore, H | 1 |
| Bulpitt, CJ | 1 |
| Brozek, B | 1 |
| Krejcí, L | 1 |
| Brettschneider, I | 1 |
| Bruck, C | 1 |
| Kaltschmidt, G | 1 |
| David, R | 1 |
| Ober, M | 2 |
| Masi, R | 1 |
| Elman, J | 1 |
| Novack, GD | 1 |
| Sears, ML | 1 |
| Batoosingh, AL | 1 |
| Pham Duy, T | 1 |
| Wollensak, J | 1 |
| Becker, U | 1 |
| Gibbens, MV | 1 |
| Romano, JH | 1 |
| Hitchings, RA | 1 |
| Pooinasawmy, D | 1 |
| Funahashi, N | 1 |
| Hayashi, A | 1 |
| Ueda, Y | 1 |
| Kawana, Y | 1 |
| Sato, H | 1 |
| Araki, Y | 1 |
| Hamanaka, T | 1 |
| Bandoh, T | 1 |
| Reddy, PS | 1 |
| Migliori, ME | 1 |
| Beckman, H | 1 |
| Channell, MM | 1 |
| Scharrer, A | 1 |
| Dausch, D | 1 |
| Gherezghiher, T | 1 |
| March, WF | 1 |
| Nordquist, RE | 1 |
| Koss, MC | 1 |
| Naveh-Floman, N | 1 |
| Stahl, V | 1 |
| Korczyn, AD | 1 |
| Kronfeld, PC | 1 |
4 reviews available for pilocarpine and Glaucoma, Suspect
| Article | Year |
|---|---|
Perioperative medications for preventing temporarily increased intraocular pressure after laser trabeculoplasty.
Topics: Adrenergic alpha-2 Receptor Agonists; Antihypertensive Agents; Brimonidine Tartrate; Clonidine; Conj | 2017 |
Latanoprost and cholinergic agonists in combination.
Topics: Antihypertensive Agents; Drug Synergism; Drug Therapy, Combination; Glaucoma, Open-Angle; Humans; In | 2002 |
Combined therapy of pilocarpine or latanoprost with timolol versus latanoprost monotherapy.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Drug Therapy, Combination; Glaucoma, Open-Angl | 2002 |
[Latanoprost topical ophthalmic combinations].
Topics: Acetazolamide; Administration, Topical; Antihypertensive Agents; Brimonidine Tartrate; Dinoprost; Dr | 2004 |
41 trials available for pilocarpine and Glaucoma, Suspect
| Article | Year |
|---|---|
The Diurnal and Nocturnal Effects of Pilocarpine on Intraocular Pressure in Patients Receiving Prostaglandin Analog Monotherapy.
Topics: Aged; Aged, 80 and over; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; Ocular H | 2018 |
Efficacy and safety of latanoprost versus pilocarpine/timolol maleate fixed combination in patients with primary open-angle glaucoma or ocular hypertension.
Topics: Aged; Drug Administration Schedule; Drug Combinations; Eye; Female; Glaucoma, Open-Angle; Humans; In | 2008 |
Timolol 0.5%/dorzolamide 2% fixed combination versus timolol 0.5%/pilocarpine 2% fixed combination in primary open-angle glaucoma or ocular hypertensive patients.
Topics: Antihypertensive Agents; Double-Blind Method; Drug Combinations; Female; Glaucoma, Open-Angle; Human | 2003 |
Additivity of pilocarpine to bimatoprost in ocular hypertension and early glaucoma.
Topics: Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Drug Synergism; Drug Therapy, Combinatio | 2005 |
An evaluation of the rate of nonresponders to latanoprost therapy.
Topics: Antihypertensive Agents; Brimonidine Tartrate; Cross-Over Studies; Drug Resistance; Glaucoma, Open-A | 2006 |
[Use of antiglaucoma therapy to reduce acute intraocular pressure rise following neodymium: YAG laser iridotomy in angle-closure glaucoma patients].
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Brimonidine Tartrate; Drug Therapy, Combination; F | 2006 |
Short-term effects of latanoprost on anterior chamber depth in patients with glaucoma or ocular hypertension.
Topics: Adult; Aged; Aged, 80 and over; Anterior Chamber; Antihypertensive Agents; Female; Glaucoma, Open-An | 2006 |
[Effect on pressure after instillation of a drop of depot-pilocarpine. Clinical results of its medium-term action].
Topics: Adult; Aged; Clinical Trials as Topic; Delayed-Action Preparations; Female; Glaucoma, Open-Angle; Hu | 1983 |
One-month crossover trial comparing the intraocular pressure control of 3.4% Piloplex twice daily with 2.0% pilocarpine four times daily.
Topics: Adult; Aged; Clinical Trials as Topic; Delayed-Action Preparations; Dose-Response Relationship, Drug | 1982 |
Efficacy and safety of timolol/pilocarpine combination drops in glaucoma patients.
Topics: Adult; Aged; Aged, 80 and over; Double-Blind Method; Drug Therapy, Combination; Female; Glaucoma; He | 1994 |
Sideport incision paracentesis versus antiglaucoma medication to control postoperative pressure rises after intraocular lens surgery.
Topics: Acetazolamide; Aged; Aqueous Humor; Cataract Extraction; Drainage; Female; Humans; Intraocular Press | 1993 |
A comparison of the efficacy of various metipranolol-pilocarpine combinations in patients with ocular hypertension and primary open-angle glaucoma.
Topics: Adult; Aged; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Female; Glaucoma, Open | 1994 |
Combined timolol and pilocarpine vs pilocarpine alone and timolol alone in the treatment of glaucoma.
Topics: Administration, Topical; Adult; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Int | 1994 |
Interaction of PhXA41, a new prostaglandin analogue, with pilocarpine. A study on patients with elevated intraocular pressure.
Topics: Aged; Aged, 80 and over; Conjunctival Diseases; Double-Blind Method; Drug Administration Schedule; D | 1993 |
[Efficacy and tolerability of 2 presentations of eyedrops combining carteolol 2% and pilocarpine 2% in primary open-angle glaucoma and simple ocular hypertension].
Topics: Adrenergic beta-Antagonists; Aged; Carteolol; Double-Blind Method; Drug Combinations; Female; Glauco | 1995 |
The use of dorzolamide and pilocarpine as adjunctive therapy to timolol in patients with elevated intraocular pressure. The Dorzolamide Additivity Study Group.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Carbonic Anhydrase Inhibitors; Chemothe | 1996 |
Ocular hypotensive efficacy and safety of a combined formulation of betaxolol and pilocarpine.
Topics: Adrenergic beta-Antagonists; Aged; Betaxolol; Double-Blind Method; Drug Therapy, Combination; Female | 1996 |
Validation of a questionnaire for comparing the tolerability of ophthalmic medications.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Eye Diseases; Female; Glaucoma, Open-An | 1997 |
A multicenter study comparing dorzolamide and pilocarpine as adjunctive therapy to timolol: patient preference and impact on daily life.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Carbonic Anhydrase Inhibitors; Chemothe | 1998 |
Two-year safety study of dorzolamide as monotherapy and with timolol and pilocarpine. Dorzolamide Safety Study Group.
Topics: Adult; Aged; Aged, 80 and over; Carbonic Anhydrase Inhibitors; Drug Therapy, Combination; Female; Gl | 1998 |
Efficacy of apraclonidine 1% versus pilocarpine 4% for prophylaxis of intraocular pressure spike after argon laser trabeculoplasty.
Topics: Aged; Clonidine; Female; Glaucoma, Open-Angle; Humans; Incidence; Intraocular Pressure; Laser Therap | 1999 |
Interaction of pilocarpine with latanoprost in patients with glaucoma and ocular hypertension.
Topics: Aged; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Female; Glaucoma, | 1999 |
Comparison of dorzolamide and pilocarpine as adjunctive therapy in patients with open-angle glaucoma and ocular hypertension.
Topics: Adjuvants, Pharmaceutic; Carbonic Anhydrase Inhibitors; Double-Blind Method; Female; Glaucoma, Open- | 1999 |
The dorzolamide/timolol combination versus timolol plus pilocarpine: patient preference and impact on daily life. United States Patient Preference Study Group. International Patient Preference Study Group.
Topics: Activities of Daily Living; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Carbonic An | 1999 |
Comparison of the intraocular pressure lowering effect of latanoprost and a fixed combination of timolol-pilocarpine eye drops in patients insufficiently controlled with beta adrenergic antagonists. French Latanoprost Study Group, and the Swedish Latanopr
Topics: Adult; Aged; Antihypertensive Agents; Drug Combinations; Female; Glaucoma; Humans; Intraocular Press | 2000 |
Comparison of brimonidine with latanoprost in the adjunctive treatment of glaucoma. ALPHAGAN/XALATAN Study Group.
Topics: Aged; Antihypertensive Agents; Brimonidine Tartrate; Cross-Over Studies; Double-Blind Method; Drug T | 2000 |
The additive intraocular pressure-lowering effect of latanoprost 0.005% daily once and pilocarpine 2% t.i.d. in patients with open-angle glaucoma or ocular hypertension. a 6-month, randomized, multicenter study. German Latanoprost Study Group.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Circadian Rhythm; Drug Administra | 2000 |
The acute effect of pilocarpine on pulsatile ocular blood flow in ocular hypertension.
Topics: Aged; Confidence Intervals; Eye; Female; Humans; Intraocular Pressure; Male; Middle Aged; Miotics; M | 2001 |
Potential mechanism for the additivity of pilocarpine and latanoprost.
Topics: Aged; Aged, 80 and over; Drug Synergism; Drug Therapy, Combination; Female; Humans; Intraocular Pres | 2001 |
Use of latanoprost to reduce acute intraocular pressure rise following neodymium: Yag laser iridotomy.
Topics: Acute Disease; Aged; Aged, 80 and over; Antihypertensive Agents; Female; Glaucoma, Angle-Closure; Hu | 2002 |
Long-term treatment with Pilogel/beta-blocker in glaucoma patients.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Drug Administration Schedule; Drug Therapy, Co | 1991 |
The effect of a glaucoma medication reminder cap on patient compliance and intraocular pressure.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Drug Labeling; Epinephrine; Female; Glaucoma; Humans; In | 1991 |
[Decrease in intraocular pressure following administration of the local carbonic anhydrase inhibitor (MK-927)--comparison of the effect with pilocarpine].
Topics: Carbonic Anhydrase Inhibitors; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Ocular Hypertensi | 1990 |
Twelve-hour IOP control obtained by a single dose of timolol/pilocarpine combination eye drops.
Topics: Administration, Topical; Aged; Aged, 80 and over; Analysis of Variance; Chi-Square Distribution; Dru | 1990 |
Efficacy and safety of the combination therapy Pilogel/beta-blocker: interim results.
Topics: Adrenergic beta-Antagonists; Aged; Betaxolol; Circadian Rhythm; Clinical Trials as Topic; Drug Thera | 1989 |
Treatment of elevated intraocular pressure with concurrent levobunolol and pilocarpine.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; H | 1987 |
[Elevation of intraocular pressure following Nd-YAG laser capsulotomy. Pathogenesis and preventive therapy].
Topics: Cataract Extraction; Drug Therapy, Combination; Humans; Indomethacin; Intraocular Pressure; Laser Th | 1987 |
The consensual ophthalmotonic reaction.
Topics: Adult; Aged; Aged, 80 and over; Epinephrine; Female; Humans; Intraocular Pressure; Male; Middle Aged | 1988 |
Role of Nd:YAG peripheral iridectomy in the management of ocular hypertension with a narrow angle.
Topics: Humans; Intraocular Pressure; Iris; Iris Diseases; Laser Therapy; Ocular Hypertension; Pilocarpine; | 1988 |
Timolol/pilocarpine combination eye drops in open angle glaucoma and in ocular hypertension. A controlled randomized study.
Topics: Aged; Clinical Trials as Topic; Drug Therapy, Combination; Glaucoma, Open-Angle; Humans; Middle Aged | 1987 |
Intraocular pressure changes after neodymium-YAG laser capsulotomy in eyes pretreated with timolol.
Topics: Humans; Laser Therapy; Lens Capsule, Crystalline; Lens, Crystalline; Ocular Hypertension; Pilocarpin | 1987 |
41 other studies available for pilocarpine and Glaucoma, Suspect
| Article | Year |
|---|---|
Pure Glaucoma Drugs Are Toxic to Immortalized Human Corneal Epithelial Cells, but They Do Not Destabilize Lipid Membranes.
Topics: Antihypertensive Agents; Apoptosis; Brimonidine Tartrate; Cell Line; Cell Membrane; Cell Survival; E | 2017 |
Urrets- Zavalia Syndrome after glaucoma filtration device implantation.
Topics: Acetazolamide; Aged; Brimonidine Tartrate; Cataract Extraction; Combined Modality Therapy; Drug Resi | 2013 |
Pilocarpine-induced dilation of Schlemm's canal and prevention of lumen collapse at elevated intraocular pressures in living mice visualized by OCT.
Topics: Animals; Aqueous Humor; Ciliary Body; Disease Models, Animal; Intraocular Pressure; Mice; Muscarinic | 2014 |
Anterior and posterior segment changes in rat eyes with chronic steroid administration and their responsiveness to antiglaucoma drugs.
Topics: Animals; Antihypertensive Agents; Brimonidine Tartrate; Catalase; Dexamethasone; Disease Models, Ani | 2015 |
Plateau iris syndrome associated with cysts and nocturnal elevation of intraocular pressure.
Topics: Adult; Ciliary Body; Circadian Rhythm; Cysts; Female; Gonioscopy; Humans; Intraocular Pressure; Iris | 2008 |
Microbead-induced ocular hypertensive mouse model for screening and testing of aqueous production suppressants for glaucoma.
Topics: Animals; Antihypertensive Agents; Aqueous Humor; Brimonidine Tartrate; Carbonic Anhydrase Inhibitors | 2012 |
[Clinical observation on the effect of 4% pilocarpine gel used one dose per day in the treatment of glaucoma].
Topics: Adolescent; Adult; Aged; Delayed-Action Preparations; Female; Gels; Glaucoma, Open-Angle; Humans; In | 2000 |
[Effects of pilocarpine in new ophthalmic formulations on intraocular pressure in rabbits with ocular hypertension].
Topics: Animals; Antihypertensive Agents; Female; Intraocular Pressure; Male; Ocular Hypertension; Ophthalmi | 2002 |
[Medical treatment of acute ocular hypertension].
Topics: Acetazolamide; Eye Diseases; Glucose; Humans; Intraocular Pressure; Ocular Hypertension; Pilocarpine | 1961 |
Use of pilocarpine following hyphaema-related ocular hypertension.
Topics: Adult; Antihypertensive Agents; Eye Injuries; Humans; Hyphema; Male; Ocular Hypertension; Pilocarpin | 2004 |
[Ocular hypertension and glaucoma].
Topics: Adult; Antihypertensive Agents; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Int | 2005 |
Pilocarpine and the increase in intraocular pressure after trabeculoplasty.
Topics: Humans; Intraocular Pressure; Ocular Hypertension; Pilocarpine; Postoperative Complications; Trabecu | 1984 |
Vascular effects of timolol and pilocarpine in the iris. A simultaneous bilateral fluorescein angiographic study.
Topics: Adult; Aged; Female; Fluorescein Angiography; Glaucoma; Humans; Iris; Male; Middle Aged; Ocular Hype | 1983 |
Metoprolol eyedrops 3%, a short-term comparison with pilocarpine and a five-month follow-up study. (Multicenter).
Topics: Adult; Aged; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Me | 1982 |
Pilocarpine-associated allograft rejection in postkeratoplasty patients.
Topics: Aged; Aged, 80 and over; Corneal Diseases; Female; Graft Rejection; Humans; Keratoplasty, Penetratin | 1995 |
The effect of treatment on the results of high-pass resolution perimetry in glaucoma.
Topics: Aged; Betaxolol; Drug Therapy, Combination; Female; Follow-Up Studies; Glaucoma; Humans; Male; Ocula | 1994 |
Pilocarpine incorporated into a submicron emulsion vehicle causes an unexpectedly prolonged ocular hypotensive effect in rabbits.
Topics: Administration, Topical; Animals; Double-Blind Method; Drug Delivery Systems; Emulsions; Hydrogen-Io | 1994 |
Visual field prognosis in early glaucoma. A long-term clinical follow-up.
Topics: Acetazolamide; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Longitudinal S | 1993 |
Ultrasound biomicroscopic findings in humans with shallow anterior chamber and increased intraocular pressure after the prone provocation test.
Topics: Acetazolamide; Administration, Oral; Aged; Anterior Chamber; Carbonic Anhydrase Inhibitors; Diagnost | 1997 |
Five-year follow-up of treated patients with glaucoma using resolution perimetry.
Topics: Aged; Betaxolol; Drug Therapy, Combination; Female; Follow-Up Studies; Glaucoma; Humans; Intraocular | 1998 |
Pharmacological evaluation of a new timolol/pilocarpine formulation.
Topics: Adrenergic beta-Antagonists; Animals; Aqueous Humor; Biological Availability; Chemistry, Pharmaceuti | 1998 |
Influence of dorzolamide on corneal thickness, endothelial cell count and corneal sensibility.
Topics: Administration, Topical; Aged; Carbonic Anhydrase Inhibitors; Cell Count; Chronic Disease; Cornea; D | 1998 |
Ocular tension and pupil diameter effects of timolol 0.50% and pilocarpine 2% or 4% in association.
Topics: Adrenergic beta-Antagonists; Aged; Chronic Disease; Drug Therapy, Combination; Female; Follow-Up Stu | 1997 |
The rarity of clinically significant rise in intraocular pressure after laser peripheral iridotomy with apraclonidine.
Topics: Adrenergic alpha-Agonists; Adult; Aged; Aged, 80 and over; Chemotherapy, Adjuvant; Clonidine; Female | 1998 |
Prevalence and management of elevated intraocular pressure in patients with Graves' orbitopathy.
Topics: Adult; Aged; Antihypertensive Agents; Decompression, Surgical; Female; Glaucoma, Open-Angle; Graves | 1998 |
Aqueous humor dynamics in alpha-chymotrypsin-induced ocular hypertensive rabbits.
Topics: Animals; Aqueous Humor; Chymotrypsin; Eye Proteins; Intraocular Pressure; Ocular Hypertension; Piloc | 1999 |
Pharmacological profile of a new topical pilocarpine formulation.
Topics: Animals; Biological Availability; Chymotrypsin; Hyaluronic Acid; Kinetics; Miosis; Ocular Hypertensi | 1999 |
[Factors influencing early post surgical ocular hypertension after phacoemulsification].
Topics: Humans; Lens Implantation, Intraocular; Miotics; Ocular Hypertension; Phacoemulsification; Pilocarpi | 2000 |
Beta-adrenergic blocker therapy and the trabecular meshwork.
Topics: Acetazolamide; Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Aqueous Humor; Drug Therapy, Co | 2001 |
Can the pilocarpine phenylephrine provocative test be used to detect covert angle closure?
Topics: Follow-Up Studies; Glaucoma, Angle-Closure; Humans; Intraocular Pressure; Iris; Ocular Hypertension; | 1991 |
Prostaglandins mediate the ocular hypotensive action of the angiotensin converting enzyme inhibitor MK-422 (enalaprilat) in African green monkeys.
Topics: Administration, Topical; Angiotensin-Converting Enzyme Inhibitors; Animals; Cercopithecus; Chloroceb | 1990 |
The progress of the visual field in chronic simple glaucoma and ocular hypertension treated topically with pilocarpine or with timolol.
Topics: Administration, Topical; Chronic Disease; Female; Glaucoma, Open-Angle; Humans; Male; Ocular Hyperte | 1990 |
Consultation section. Uniocular extracapsular cataract extraction.
Topics: Glaucoma; Humans; Hyphema; Lenses, Intraocular; Male; Middle Aged; Ocular Hypertension; Pilocarpine | 1990 |
[The effect of adrenaline, pilocarpine and timolol on axoplasmic transport in the optic nerve. II. Findings in eyes with increased intraocular pressure].
Topics: Animals; Axonal Transport; Epinephrine; Female; Ocular Hypertension; Optic Nerve; Pilocarpine; Rats; | 1985 |
[The Booster test in the diagnosis of glaucoma].
Topics: Adult; Aged; Diagnosis, Differential; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle A | 1989 |
[Acute angle-closure glaucoma after general anesthesia].
Topics: Acute Disease; Anesthesia, General; Female; Glaucoma; Humans; Intubation, Intratracheal; Middle Aged | 1988 |
Therapeutic problems in ocular hypertension.
Topics: Drug Therapy, Combination; Epinephrine; Humans; Ocular Hypertension; Pilocarpine; Risk Factors; Timo | 1988 |
[Guanethidine/dipivefrin and pilocarpine in the treatment of increased intraocular pressure].
Topics: Drug Therapy, Combination; Epinephrine; Glaucoma, Open-Angle; Guanethidine; Humans; Intraocular Pres | 1987 |
Laser-induced glaucoma in rabbits.
Topics: Animals; Aqueous Humor; Colforsin; Disease Models, Animal; Glaucoma; Lasers; Ocular Hypertension; Op | 1986 |
Effect of pilocarpine on intraocular pressure in ocular hypertensive subjects.
Topics: Humans; Intraocular Pressure; Middle Aged; Ocular Hypertension; Pilocarpine; Receptors, Muscarinic; | 1986 |
The efficacy of combinations of ocular hypotensive drugs. A tonographic approach.
Topics: Drug Evaluation; Drug Therapy, Combination; Echothiophate Iodide; Epinephrine; Female; Glaucoma, Ope | 1967 |